BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
11/14/2018 - NAD Recommends Health Club Diet, LLC Discontinue Health-Related Advertising Claims for Androzene Supplement Following CRN Challenge.
The National Advertising Division determined that Internet advertising claims made by Health Club Diet, LLC for its Androzene dietary supplement were unsupported and recommended that the advertiser’s claims be discontinued. -
11/14/2018 - Hyperbiotics Says it Will Discontinue Advertising Claims for Probiotic Supplements Following Challenge by P&G
Hyperbiotics, Inc. said the company has permanently discontinued certain challenged advertising claims for the company’s Hyperbiotics probiotic supplements, including claims that its products are “15X more effective than others.” -
10/31/2018 - Following AT&T Challenge, T-Mobile Says Disputed Claim Has Been Discontinued, NAD Declines to Review Claim on its Merits
Following a challenge by AT&T Services Inc., T-Mobile USA, Inc., said a television commercial that contained the claim “Only T-Mobile lets you watch your favorite movies and shows in more places without paying more,” has completed its run and the claim has been discontinued. NAD did not review the claim on its merits. -
10/23/2018 - NAD Refers Advertising Claims by The a2 Milk Company for Further Review After Company Declines to Participate in NAD Proceeding
The National Advertising Division has referred advertising claims made by The a2 Milk Company (a2MC) for its a2 Milk product to the Federal Trade Commission (FTC) for further review, after the advertiser declined to participate in a review of its advertising claims, including claims that its product is “Easier on digestion” and “May help some avoid discomfort.” -
10/19/2018 - NAD Refers Advertising Claims by LG Electronics to FTC for Further Review; NAD Declines to Reopen LG Case Under New Evidence Rules
The National Advertising Division has referred advertising claims made by LG Electronics USA, Inc., to the Federal Trade Commission (FTC) for further review, following LG’s decision against complying with NAD recommendations regarding claims to “perfect black” and “infinite contrast.” -
10/10/2018 - NAD Recommends AT&T Modify, Discontinue Certain Claims in ‘More for Your Thing’ Campaign; Advertiser to Appeal Adverse Findings
The National Advertising Division has recommended that AT&T Services Inc., modify or discontinue certain claims made as part of the company’s “More for Your Thing,” advertising campaign. AT&T said it will appeal those adverse findings to the National Advertising Review Board (NARB). -
10/02/2018 - NAD Recommends Comcast Discontinue Implied Claim About DirecTV’s Reliability, Availability of Free Shows; Both Parties to Appeal Certain NAD Findings
The National Advertising Division has recommended that Comcast Cable Communications, LLC, discontinue the implied claim, featured in a broadcast advertisement, that DirecTV is highly unreliable in bad weather and modify its advertising to avoid conveying the message that DirecTV offers no free shows or movies on the go. -
9/21/2018 - NAD Recommends Philips Oral Healthcare Modify Certain Claims for ‘Sonicare DiamondClean’ Toothbrush
The National Advertising Division has recommended that that Philips Oral Healthcare, Inc., modify certain advertising claims for the company’s Sonicare DiamondClean toothbrush, following a challenge by The Procter & Gamble Company, maker of Oral-B oral health products. -
9/17/2018 - NAD Refers Advertising Claims for Cross Brands ‘Sea & Ski’ Sun Care Products to FTC, FDA for Further Review
The National Advertising Division has referred advertising claims made by Cross Brands Manufacturing, LLC, for the company’s Sea & Ski brand sun care products, to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) after the company declined to state whether it would comply with NAD’s recommendations to discontinue certain advertising claims. -
8/23/2018 - NAD Refers Claims for Aubio’s Cold Sore Treatment Gel to FDA, FTC for Further Review Following GSK Challenge
The National Advertising Division has referred to the Food and Drug Administration (FDA) and Federal Trade Commission (FTC) advertising claims made by Aubio Life Sciences for its Cold Sore Treatment Gel that communicate the product provides relief at the “first sign” of a cold sore or during the “tingling” phase of an outbreak.